Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Chuang, Chi Mu ^a,b,c   Monie, Archana ^a   Wu, Annie ^a   Hung, Chien Fu ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; HEAT SHOCK PROTEIN 70; PROTEIN E7; VIRUS DNA; WART VIRUS VACCINE; ANTINEOPLASTIC AGENT; DNA VACCINE; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG POTENTIATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR XENOGRAFT; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MUS;

ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; APIGENIN; APOPTOSIS; COMBINED MODALITY THERAPY; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS VACCINES; VACCINES, DNA;

EID: 67651100519     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-49     Document Type: Article

References (29)

1. DNA vaccines. JJ Donnelly JB Ulmer MA Liu, Life Sci 1997 60 163 172 10.1016/S0024-3205(96)00502-4 9000640 (Pubitemid 27035670)
2. DNA vaccines: immunology, application, and optimization. S Gurunathan DM Klinman RA Seder, Annu Rev Immunol 2000 18 927 974 10.1146/annurev.immunol.18.1. 927 10837079 (Pubitemid 30365401)
3. Improving DNA vaccine potency via modification of professional antigen presenting cells. CF Hung TC Wu, Curr Opin Mol Ther 2003 5 20 24 12669466
4. Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells. SW Tsen AH Paik CF Hung TC Wu, Expert Rev Vaccines 2007 6 227 239 10.1586/14760584.6.2.227 17408372 (Pubitemid 46607458)
5. DNA vaccines: precision tools for activating effective immunity against cancer. J Rice CH Ottensmeier FK Stevenson, Nat Rev Cancer 2008 8 108 120 10.1038/nrc2326 18219306 (Pubitemid 351161331)
6. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. CH Chen TL Wang CF Hung Y Yang RA Young DM Pardoll TC Wu, Cancer Res 2000 60 1035 1042 10706121
7. A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3. CL Trimble S Peng F Kos P Gravitt R Viscidi E Sugar D Pardoll T-C Wu, Clinical Cancer Research 2008 18483387
8. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. T Hussain S Gupta VM Adhami H Mukhtar, Int J Cancer 2005 113 660 669 10.1002/ijc.20629 15455372 (Pubitemid 40038745)
9. (-)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: evidences for the COX-2 and STAT1 as potential targets. YI Jeong ID Jung JS Lee CM Lee JD Lee YM Park, Biochem Biophys Res Commun 2007 354 1004 1009 10.1016/j.bbrc.2007.01.076 17270146 (Pubitemid 46216233)
10. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. H Czeczot B Tudek J Kusztelak T Szymczyk B Dobrowolska G Glinkowska J Malinowski H Strzelecka, Mutat Res 1990 240 209 216 10.1016/0165-1218(90)90060-F 2179716
11. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. SH Lee JK Ryu KY Lee SM Woo JK Park JW Yoo YT Kim YB Yoon, Cancer Lett 2008 259 39 49 10.1016/j.canlet.2007.09.015 17967505 (Pubitemid 350235089)
12. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. D Chen KR Landis-Piwowar MS Chen QP Dou, Breast Cancer Res 2007 9 R80 18300387 10.1186/bcr1797
13. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. S Shukla S Gupta, Free Radic Biol Med 2008 44 1833 1845 18342637 10.1016/j.freeradbiomed.2008.02.007
14. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. KY Lin FG Guarnieri KF Staveley-O'Carroll HI Levitsky JT August DM Pardoll TC Wu, Cancer Res 1996 56 21 26 8548765
15. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. TL Wang M Ling IM Shih T Pham SI Pai Z Lu RJ Kurman DM Pardoll TC Wu, Gene Ther 2000 7 726 733 10.1038/sj.gt.3301160 10822298
16. Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency. B Huang CP Mao S Peng L He CF Hung TC Wu, Vaccine 2007 25 7824 7831 17931752 10.1016/j.vaccine.2007.08.036 (Pubitemid 47588522)
17. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. W Wang PC VanAlstyne KA Irons S Chen JW Stewart DF Birt, Nutr Cancer 2004 48 106 114 10.1207/s15327914nc4801-14 15203384
18. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. K Suzue RA Young, J Immunol 1996 156 873 879 8543845
19. Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. H Ji TL Wang CH Chen SI Pai CF Hung KY Lin RJ Kurman DM Pardoll TC Wu, Hum Gene Ther 1999 10 2727 2740 10.1089/10430349950016474 10584920
20. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. PW Zheng LC Chiang CC Lin, Life Sci 2005 76 1367 1379 10.1016/j.lfs.2004.08.023 15670616
21. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. TH Kang JH Lee CK Song HD Han BC Shin SI Pai CF Hung C Trimble JS Lim TW Kim TC Wu, Cancer Res 2007 67 802 811 10.1158/0008-5472.CAN-06-2638 17234792 (Pubitemid 46192221)
22. Pretreatment with Cisplatin Enhances E7-Specific CD8+ T-Cell-Mediated Antitumor Immunity Induced by DNA Vaccination. CW Tseng CF Hung RD Alvarez C Trimble WK Huh D Kim CM Chuang CT Lin YC Tsai L He, Clin Cancer Res 2008 14 3185 3192 10.1158/1078-0432.CCR-08-0037 18483387
23. Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination. CW Tseng A Monie CY Wu B Huang MC Wang CF Hung TC Wu, J Mol Med 2008 86 899 908 10.1007/s00109-008-0370-y 18542898
24. Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity. A Kanerva M Raki T Ranki M Sarkioja J Koponen RA Desmond A Helin UH Stenman H Isoniemi K Hockerstedt, J Gene Med 2007 9 3 9 10.1002/jgm.984 17149790 (Pubitemid 46210950)
25. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. MA Gates SS Tworoger JL Hecht I De Vivo B Rosner SE Hankinson, Int J Cancer 2007 121 2225 2232 10.1002/ijc.22790 17471564 (Pubitemid 47585602)
26. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. K Munger JR Basile S Duensing A Eichten SL Gonzalez M Grace VL Zacny, Oncogene 2001 20 7888 7898 10.1038/sj.onc.1204860 11753671
27. A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity. CT Lin YC Tsai L He R Calizo HH Chou TC Chang YK Soong CF Hung CH Lai, J Biomed Sci 2006 13 481 488 10.1007/s11373-006-9086-6 16649071
28. Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. WJ Liu F Gao KN Zhao W Zhao GJ Fernando R Thomas IH Frazer, Virology 2002 301 43 52 10.1006/viro.2002.1584 12359445 (Pubitemid 35168500)
29. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. C Trimble CT Lin CF Hung S Pai J Juang L He M Gillison D Pardoll L Wu TC Wu, Vaccine 2003 21 4036 4042 10.1016/S0264-410X(03)00275-5 12922140 (Pubitemid 37345135)